Related Experiment Video
Updated: Sep 29, 2025

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
DNA repair defects in cancer and therapeutic opportunities
Jessica L Hopkins1, Li Lan1,2, Lee Zou1,3
1Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA.
Abstract:
DNA repair and DNA damage signaling pathways are critical for the maintenance of genomic stability. Defects of DNA repair and damage signaling contribute to tumorigenesis, but also render cancer cells vulnerable to DNA damage and reliant on remaining repair and signaling activities. Here, we review the major classes of DNA repair and damage signaling defects in cancer, the genomic instability that they give rise to, and therapeutic strategies to exploit the resulting vulnerabilities. Furthermore, we discuss the impacts of DNA repair defects on both targeted therapy and immunotherapy, and highlight emerging principles for targeting DNA repair defects in cancer therapy.
Insights
DNA repair and damage signaling are vital for genomic stability. Defects in these pathways drive cancer but create vulnerabilities that can be exploited for new cancer therapies.
Area of Science:
- Genomic stability and cancer biology
- Molecular oncology
- DNA repair mechanisms
Background:
- DNA repair and damage signaling pathways are crucial for maintaining genomic stability.
- Defects in these pathways contribute to cancer development (tumorigenesis).
- Cancer cells with DNA repair defects exhibit unique vulnerabilities.
Purpose of the Study:
- To review major DNA repair and damage signaling defects in cancer.
- To discuss the resulting genomic instability and therapeutic strategies.
- To explore the impact of these defects on targeted therapy and immunotherapy.
Main Methods:
- Literature review of DNA repair and damage signaling in cancer.
- Analysis of genomic instability arising from repair defects.
- Discussion of therapeutic strategies targeting these vulnerabilities.
Main Results:
- Identification of major classes of DNA repair and damage signaling defects in cancer.
- Understanding how these defects lead to genomic instability.
- Exploration of therapeutic vulnerabilities created by these defects.
Conclusions:
- DNA repair defects are central to cancer development and progression.
- Targeting DNA repair vulnerabilities offers promising therapeutic avenues.
- Emerging principles focus on exploiting these defects in cancer treatment, including immunotherapy.
More Related Videos
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
04:07Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Published on: February 24, 2023
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Overview of DNA Repair
Chemically...
DNA Damage can Stall the Cell Cycle
Long-patch Base Excision Repair
Targeted Cancer Therapies
There are several types of targeted therapies against...
Base Excision Repair
The first step of...